Analyst firms · Truist Securities · ICLR

Truist Securities ICLR price target and rating history

ICON plc (ICLR) · Health Care

Truist Securities rates ICON plc (ICLR) Buy with a $207 price target, as of its latest action on Jun 30, 2026. It has published 3 rating actions on ICLR since December 2023, including 1 upgrade and 1 downgrade. Across 9 firms with a ICLR price target in the last 12 months, the median target is $135. Truist Securities's $207 is 53% above that.

Current rating
Buy
Price target
$207
Median target, all firms
$135
Actions on ICLR
3

Truist Securities price target on ICLR

$357$282$207202420252026
Truist Securities price target on ICLR, each point a stated target, December 2023 to June 2026.

Every Truist Securities rating on ICLR

How other firms rate ICLR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BofA SecuritiesNeutral$185Oct 9, 2026
UBSNeutral$195Sep 30, 2026
Truist SecuritiesBuy$207Jun 30, 2026
RBC Capital MarketsOutperform$185Jun 25, 2026
BMO Capital MarketsOutperform$130Mar 26, 2026
JefferiesBuy$135Feb 23, 2026
TD CowenBuy$120Feb 18, 2026
Rothschild & Co RedburnNeutral$100Feb 17, 2026
Leerink PartnersMarket Perform$105Feb 12, 2026

Questions about Truist Securities and ICLR

What is Truist Securities's price target for ICLR?
Truist Securities's latest stated price target for ICON plc (ICLR) is $207, from its action on Jun 30, 2026.
What is Truist Securities's rating on ICLR?
Truist Securities rates ICLR Buy, a bullish rating, as of Jun 30, 2026.
When did Truist Securities last change its view on ICLR?
On Jun 30, 2026, Truist Securities upgrades to Buy from Hold, price target $207.
How does Truist Securities's ICLR target compare with other analysts?
Across 9 firms with a ICLR price target in the last 12 months, the median target is $135. Truist Securities's $207 is 53% above that.

More ICLR rating histories

All Truist Securities ratingsICLR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.